SCHEMBL4905375

SCHEMBL4905375

CNC(=O)n1cccc1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.40
APEX1 P27695 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
PKM P14618 1/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4379296 0.78 POLB (0.43) POLBAPEX1TDP1L3MBTL1NPC1
SCHEMBL4334753 0.77 TDP1 (0.46) POLBAPEX1TDP1L3MBTL1NPC1
SCHEMBL165613 0.76 BCHE (0.42) POLBBCHEACHESMN1; SMN2BRD4
SCHEMBL14398922 0.74 POLB (0.41) POLBAPEX1TDP1L3MBTL1NPC1
SCHEMBL4904690 0.74 TDP1 (0.43) POLBAPEX1TDP1L3MBTL1BCHE
SCHEMBL4913277 0.73 POLB (0.40) POLBAPEX1TDP1L3MBTL1BCHE
SCHEMBL13719988 0.72 POLB (0.42) POLBAPEX1TDP1L3MBTL1NPC1
SCHEMBL26119733 0.70 LPO (0.45) POLBAPEX1TDP1L3MBTL1BCHE
SCHEMBL6794236 0.69 L3MBTL1 (0.40) POLBAPEX1TDP1L3MBTL1BCHE
SCHEMBL28614024 0.69 POLB (0.40) POLBAPEX1TDP1L3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080233410-A1 Transition metal complex compound IDEMITSU KOSAN CO., LTD. (JP) 2008-09-25 US disclosed
US-20070141397-A1 TRANSITION METAL COMPLEX COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE COMPOUND IDEMITSU KOSAN CO., LTD (JP) 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080233410-A1 Transition metal complex compound EMC2, INTS9, LEF1 POLB 1784/4885APEX1 518/4885TDP1 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.